Last reviewed · How we verify
NCT03593148: LIFETIME
The Effect of Lifestyle Treatment in Patients With Morbid Obesity
NA trial testing Lifestyle in Physical Capacity in 600 participants. Status unknown.
23 December 2025
Quick facts
| Lead sponsor | Sykehuset i Vestfold HF |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 600 |
| Start date | 1 April 2017 |
| Primary completion | 23 December 2025 |
| Estimated completion | 23 December 2025 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Lifestyle
Conditions studied
- Physical Capacity — all drugs for Physical Capacity →
- Leg Strength — all drugs for Leg Strength →
- Eating Behavior — all drugs for Eating Behavior →
- Life of Quality — all drugs for Life of Quality →
Sponsor
Sykehuset i Vestfold HF — full company profile →
Who can join
Adults 18 to 99, any sex, with Physical Capacity or Leg Strength. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The effect of lifestyle treatment on physical capacity, maximal strength, eating behavior and quality of life in patients with morbid obesity (LIFETIME)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Machine Learning for Estimating Cardiorespiratory Fitness in Patients With Obesity: Protocol for a Retrospective and Prospective Multicenter Cohort Study.
Berge J, Nunavath V, Asbjørnsen RA, Borgeraas H, et al · · 2026 · PMID 41773679 · DOI 10.2196/85069
Verify or expand the search:
- PubMed search for NCT03593148
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lifestyle
Trials testing the same drug.
- NCT06230744 — A Novel Intervention for Weight Loss in Young Adults · NA · recruiting
- NCT06439758 — Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes · Phase 4 · not yet recruiting
- NCT06866093 — The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical. · active not recruiting
- NCT05338944 — Dialectal Behaviour Therapy to Enhance Health Behaviour Change for Adolescents Living With Obesity (DIRECTION Trial) · NA · recruiting
- NCT04761250 — The Effect of a Multimodal Lifestyle Program on Male Fertility · NA · completed
Other Sykehuset i Vestfold HF trials
Trials by the same sponsor.
- NCT07011108 — Machine Learning for Estimating Cardiorespiratory Fitness in Patients With Obesity · active not recruiting
- NCT06468865 — Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery · NA · recruiting
- NCT06045741 — Virtual Reality - A New Vision on Pain · completed
- NCT05858255 — Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study · NA · recruiting
- NCT04659395 — How to Develop a Training Program for Nurses in Ultrasound Guided Femoral Nerve Block · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03593148 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sykehuset i Vestfold HF
- Last refreshed: 1 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03593148.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing